YU37696A - Postupak optičkog prečišćavanja jedinjenja - Google Patents

Postupak optičkog prečišćavanja jedinjenja

Info

Publication number
YU37696A
YU37696A YU37696A YU37696A YU37696A YU 37696 A YU37696 A YU 37696A YU 37696 A YU37696 A YU 37696A YU 37696 A YU37696 A YU 37696A YU 37696 A YU37696 A YU 37696A
Authority
YU
Yugoslavia
Prior art keywords
compounds
optical purification
purification
optical
sulfinyl
Prior art date
Application number
YU37696A
Other languages
English (en)
Inventor
Unge Sverker Von
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20397468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU37696(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of YU37696A publication Critical patent/YU37696A/sh
Publication of RS49826B publication Critical patent/RS49826B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Abstract

Postupak optičkog prečišćavanja pojedinačnih enantiomera nekih derivata 2-sulfinil-1H-benzimidazola i drugih strukturno srodnih sulfoksida, iz njihovih preparata koji su obogaćeni odgovarajućim enantiomerom.
YUP-376/96A 1995-07-03 1996-06-19 Postupak optičkog prečišćavanja preparata obogaćenog enantiomerom omeprazola RS49826B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500817 1995-07-03

Publications (2)

Publication Number Publication Date
YU37696A true YU37696A (sh) 1999-03-04
RS49826B RS49826B (sr) 2008-08-07

Family

ID=20397468

Country Status (37)

Country Link
US (1) US5929244A (sh)
EP (2) EP0836601B1 (sh)
JP (1) JP4195507B2 (sh)
KR (1) KR100451078B1 (sh)
CN (1) CN1098261C (sh)
AT (1) ATE418549T1 (sh)
AU (1) AU698638B2 (sh)
BR (1) BR9609450A (sh)
CA (1) CA2226184C (sh)
CZ (1) CZ295430B6 (sh)
DE (1) DE69637788D1 (sh)
DK (1) DK0836601T3 (sh)
DZ (1) DZ2057A1 (sh)
EE (1) EE03444B1 (sh)
ES (1) ES2318850T3 (sh)
HK (1) HK1010193A1 (sh)
HR (1) HRP960232A2 (sh)
HU (1) HUP9901717A3 (sh)
IL (1) IL122811A (sh)
IS (1) IS2666B (sh)
MA (1) MA23921A1 (sh)
MY (1) MY114018A (sh)
NO (1) NO313008B1 (sh)
NZ (1) NZ311842A (sh)
PL (1) PL186702B1 (sh)
PT (1) PT836601E (sh)
RS (1) RS49826B (sh)
RU (1) RU2144031C1 (sh)
SA (1) SA96170103B1 (sh)
SI (1) SI0836601T1 (sh)
SK (1) SK284780B6 (sh)
TN (1) TNSN96090A1 (sh)
TR (1) TR199701754T1 (sh)
TW (1) TW444010B (sh)
UA (1) UA49838C2 (sh)
WO (1) WO1997002261A1 (sh)
ZA (1) ZA965205B (sh)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6051570A (en) * 1997-05-30 2000-04-18 Dr. Reddy's Research Foundation Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
AU742620B2 (en) * 1998-01-30 2002-01-10 Sepracor, Inc. R-lansoprazole compositions and methods
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
US6608092B1 (en) 1999-06-30 2003-08-19 Takeda Chemical Industries, Ltd. Crystals of benzimidazole compounds
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
KR101035534B1 (ko) 2000-05-15 2011-05-23 다케다 야쿠힌 고교 가부시키가이샤 결정의 제조방법
CA2417311C (en) 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
KR100887912B1 (ko) 2000-12-01 2009-03-12 다케다 야쿠힌 고교 가부시키가이샤 (ｒ)- 또는 (ｓ)-란소프라졸의 결정화 방법
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0104295D0 (sv) * 2001-12-18 2001-12-18 Astrazeneca Ab New process
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
EP2596792A1 (en) 2002-10-16 2013-05-29 Takeda Pharmaceutical Company Limited Stable solid preparations
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
JP2006514985A (ja) 2002-12-06 2006-05-18 アルタナ　ファルマ　アクチエンゲゼルシャフト （ｓ）−パントプラゾールの製造方法
PT1578742E (pt) 2002-12-06 2013-01-24 Nycomed Gmbh Processo para preparar compostos activos opticamente puros
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
CA2517714A1 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Polymorphs of s-omeprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531566C (en) * 2003-07-18 2013-05-07 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
FR2863609A1 (fr) * 2003-12-15 2005-06-17 Isochem Sa Procede d'enrichissement enantiomerique d'un melange d'enantiomeres d'alpha-aminoacides
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
WO2008152462A1 (en) * 2007-06-15 2008-12-18 Emcure Pharmaceuticals Limited A process of sulfoxidation of biologically active compounds
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
NZ588379A (en) 2008-03-10 2012-07-27 Takeda Pharmaceutical Crystal of benzimidazole compound
WO2010058409A2 (en) 2008-11-18 2010-05-27 Hetero Research Foundation Optical purification of esomeprazole
KR101001646B1 (ko) * 2008-12-12 2010-12-17 한미약품 주식회사 (ｒ)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
US8748619B2 (en) 2009-11-12 2014-06-10 Hetero Research Foundation Process for the resolution of omeprazole
US20130197232A1 (en) 2010-01-29 2013-08-01 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
US10071996B2 (en) 2014-07-30 2018-09-11 Aetas Pharma Co., Ltd. Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same
ES2615637T3 (es) * 2015-03-06 2017-06-07 F.I.S.- Fabbrica Italiana Sintetici S.P.A. Procedimiento mejorado para la purificación óptica del esomeprazol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
US5149702A (en) * 1989-11-29 1992-09-22 Toa Eiyo Ltd. Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds

Also Published As

Publication number Publication date
DK0836601T3 (da) 2009-03-16
RU2144031C1 (ru) 2000-01-10
EE03444B1 (et) 2001-06-15
MY114018A (en) 2002-07-31
SI0836601T1 (sl) 2009-04-30
WO1997002261A1 (en) 1997-01-23
US5929244A (en) 1999-07-27
SA96170103B1 (ar) 2006-07-30
CZ295430B6 (cs) 2005-08-17
EP0836601B1 (en) 2008-12-24
EP1498416A1 (en) 2005-01-19
MX9800160A (es) 1998-03-31
JPH11508590A (ja) 1999-07-27
PL186702B1 (pl) 2004-02-27
CN1193971A (zh) 1998-09-23
HK1010193A1 (en) 1999-06-17
EE9700368A (et) 1998-06-15
IS4638A (is) 1997-12-22
ZA965205B (en) 1997-01-03
RS49826B (sr) 2008-08-07
NO313008B1 (no) 2002-07-29
DZ2057A1 (fr) 2002-10-20
EP0836601A1 (en) 1998-04-22
HRP960232A2 (en) 1998-02-28
IL122811A (en) 2000-11-21
ATE418549T1 (de) 2009-01-15
KR100451078B1 (ko) 2004-11-16
CA2226184A1 (en) 1997-01-23
UA49838C2 (uk) 2002-10-15
SK284780B6 (sk) 2005-11-03
CZ421197A3 (cs) 1998-06-17
JP4195507B2 (ja) 2008-12-10
CN1098261C (zh) 2003-01-08
NO976030L (no) 1998-02-09
HUP9901717A2 (hu) 2000-04-28
KR19990028631A (ko) 1999-04-15
IL122811A0 (en) 1998-08-16
TW444010B (en) 2001-07-01
NZ311842A (en) 1998-12-23
MA23921A1 (fr) 1996-12-31
SK179397A3 (en) 1998-09-09
CA2226184C (en) 2008-08-05
TNSN96090A1 (fr) 2005-03-15
AU698638B2 (en) 1998-11-05
DE69637788D1 (de) 2009-02-05
BR9609450A (pt) 1999-03-02
AU6324096A (en) 1997-02-05
HUP9901717A3 (en) 2002-03-28
IS2666B (is) 2010-08-15
PL324394A1 (en) 1998-05-25
TR199701754T1 (xx) 1998-04-21
PT836601E (pt) 2009-02-17
ES2318850T3 (es) 2009-05-01
NO976030D0 (no) 1997-12-22

Similar Documents

Publication Publication Date Title
YU37696A (sh) Postupak optičkog prečišćavanja jedinjenja
IS4226A (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
DE69526594D1 (de) Direktverfahren zur herstellung von zelluloseestern
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
ATE283264T1 (de) Zwischenprodukte zur herstellung von metallproteinasehemmern
DE69427848D1 (de) Unterstützungssystem zur Herstellung von Wörterbüchern
DE69011151D1 (de) Ultraviolettunterdrückte Lichtquelle, dafür verwendeter Beschichtungsstoff und Verfahren zu seiner Herstellung.
DE69423179T2 (de) Prozess zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten
DE69623429T2 (de) Verfahren zur kontinuierlichen Herstellung von aromatischen Carbonaten
DE69502384T2 (de) Prozess zur herstellung von polyarylenetherketonen
ATE227723T1 (de) Eintopfverfahren zur herstellung von 2- oxazolidinonderivate
DE69600983T2 (de) Kapselpräparate zur Behandlung von Pflanzen
DE59300418D1 (de) Verfahren zur Herstellung von natürlichen Antioxidantien.
DK0840724T3 (da) Fremgangsmåde til fremstilling af enantiomerisk ren azetidin-2-caboxylsyre
NO990450D0 (no) Behandling av sinnslidelser
DE69317237D1 (de) Verfahren zur Herstellung von abriebfesten, transparenten Teilen
DE69625562T2 (de) Verfahren zur Herstellung von optisch aktiven Cyclohexanolderivaten
DK0852578T3 (da) Fremgangsmåde til fremstilling af visse acetonitriler
ATE315583T1 (de) Analoge des thymosin alpha 1
DE59606696D1 (de) Verfahren zur Herstellung von trans-2, cis-4-Decadiensäureethylester
DE29504820U1 (de) Präsentationsrahmen, zur Aufnahme von Minipuzzle